Upload
others
View
4
Download
0
Embed Size (px)
Citation preview
15-16 May, 2017
Regal International East Asia Hotel
Shanghai
S h o w c a s e
SEBP2017S i n o - E u r o B i o Pa r t n e r i n g中欧生物医药合作暨投融资大会
Fenglin Forum
http://www.sebpchina.com
I n v e s t m e n t
P a r t n e r i n g
I n n o v a t i o n
Sino-Euro BioPartnering (SEBP) is anannual conference which provides acost-effective and tailor-madepartnership platform for Europeanand other international SMEs topartner with local companies andinvestors.
SEBP was first launched by G-MedConsulting, Bioclouds, BiowinLyonbiopole and Juke Science Park in2013 in Shanghai. Since then, theorganizers have successfully organizedfour conferences, and supportednumerous of industry leaders andinvestors. The organizers offer pre-selection, onsite support and follow-up services for European and USparticipants and have establishedstrong network with bioclusters,academia, hospitals, industry and theinvestment societies.
Biotech, Pharma & Medtech
Industry Trend and Insight
Investment Guide in Europe & US
Europe & US SME Showcase
Customized Partnering Platform
Academic - Hospital - Industry
www.sebpchina.com
SEBP2017S i n o - E u r o B i o Pa r t n e r i n g中欧生物医药合作暨投融资大会
15-16th May, 2017 Regal East Asia, Shanghai
SAVE THE DATE!
Partnership: Research – Clinic – Business – Investment
SEBP2017Agenda
Sino-Euro BioPartnering 2017
Monday, 15th May, 2017
Site: Regal International East Asia Hotel
08:00--09:00 Registration
09:00--09:30
Opening Address by Xuhui Mayor
Address by President of European Union Chamber of Commerce in China (TBC)
bioXclusters China Gateway signing ceremony
Announcement of Fenglin BioMedical Centre Opening
09:30--10:45
Plenary 9:30-9:50 Keynote 1: “Opportunities and Challenges of the future biomedical industry under the new medical policy in China” by Mr. Yu Ming De, Chairman, China Pharmaceutical Enterprises Association
9:50-10:10 Keynote 2: “Precision medicine practice in cancer treatment” by Vice President, Shanghai Cancer Hospital. (TBC)
10:10-10:30 Keynote 3: “Overview of China Biomedical Industry” by Ms. Tina Hou, Associate Partner, McKiensey & Co.
10:30-10:40 Presentation: “The Fenglin BioMedical Centre" by Mr. Rong Hui Gao, Managing Director, Fenglin BioMedical Centre; CEO, G-Med Consulting10:40-10:50 “The bioXclusters meta-cluster” by bioXclusters Project Leader
10:45--11:00 Coffee break
11:00--12:00
Showcase I Session I (6 companies)
1. Cold Ablation Robot-guided Laser Osteotome
2. A micro engineering and nano technology company to provide modern solution to treat glaucoma
3. A major technological advance in the radiation treatment of cancerous tumors
4. tbc
5. tbc
6. tbc
Moderator: Mr. Fabrizio Conicella, General Manager Bioindustry Park SilvanoFumero SPA, bioXclusters representative
12:00--13:00 Lunch Lunch and network
13:00--13:20 Topic “Precision Medicine” by Roche (TBC)
Panel Discussion I
Panel discussion 1: “How can innovation improve precision medicine?”
13:20--14:00
Moderator: Mr. Fu Da Xu, Managing Director, Shanghai Center of Biomedicine Development
Ke Hua Bio-EngineeringJ&J Innovation CenterRoche Diagnostics
3S Bio Inc.
WuXi AppTec
Lv Ye Pharmaceutical
14:00--15:00
Showcase II Session II
1. A gene editing company develops advanced gene-editing medicines to treat HIV
2. An emerging personalized medicine leader in cellular therapies and tissue engineering, with focus on bone, skin, and cartilage regeneration.
3. A company working to treat hair loss through the use of non-embryonic stem cells
4. tbc
5. tbc
6. tbc
Moderator: Brett Johnson, CEO, OneMed Market
15:00--15:15 Coffee break
www.sebpchina.com
Partnership: Research – Clinic – Business – Investment
SEBP2017Agenda
Sino-Euro BioPartnering 2017
Monday, 15th May, 2017
Site: Regal International East Asia Hotel
15:15--16:00
TopicPanel
Discussion II
Investment
Panel discussion 2: “Cross border partnership and investment opportunities”
Moderator: Mr. Rong Hui Gao, Managing Director, Fenglin BioMedical Centre; CEO G-Med Consulting
Xin Hua Medical
Sinopharm
Fosun Tongde
Shanghai Pharma
bioXclusters
16:00—17:30
ShowcaseIII
Session III (5-8 drug development companies)
1. Trifunctional, bispecific immuno-oncology technology platform
2. New ingredients for bone health
3. Phase II drug development to treat Gout and heart failure
4. tbc
5. tbc
6. tbc
Moderator: Zhang Jiong, General Manager, Juke Biotech Park
17:00--17:10 Closing Summary
-------- Invitation Only-------
Tuesday, 16th May, 2017
Site: Fenglin International Biomedical Center
9:00—9:05 Opening Mr. Wu Yin Fei, President, Fenglin Life Healthcare Group
9:05--10:05
Hopsital Introduction
Zhongshan Hospital (Affiliated to Fudan University Medical College) TBC
No. 6 People's Hospital (specialty on Diabetes and Othorpedics) TBC
10:05--10:35
Panel Topic: Clinical trial and registration in China
Moderator: Mr. Rong Hui Gao, Managing Director, Fenglin BioMedical Centre; CEO, G-Med Consulting
Quintiles IMS
McKinsey & Co.
Han Kun Law Office
Med-Link
10:35--10:50 Coffee break
10:50--12:00 Company introduction: Shanghai Pharm, China Grand, Wondfo Plc, Comermy Plc
12:00--13:00 Lunch Lunch and network
13:00--13:30
Visit
Visit Fenglin BioMedical Centre
13:30--14:30 Visit Shanghai Institute of Organic Chemistry
15:00--16:30 Visit Shanghai Cancer Center (Affiliated to Fudan University)
17:00--17:10 Closing Summary
www.sebpchina.com
A TAILORED PLATFORM FOR COLLABORATION
MEET WITH THE RIGHT LOCAL PARTNERS
| Some major participants in 2017
Hospitals
Pharmaceutical
Medical Device Companies
CROs
Consulting
Sponsorship Packages
Platinum Diamond Gold Silver
RMB 200,000 RMB 100,000 RMB 50,000 RMB 20,000
Registration
Free passes 10 5 3 3
Panel discussion
Panelist yes yes - -
Showcase yes yes - -
Presentation slot 1 1 1 -
Booth and logo display
Booth* yes yes - -
Logo on name tag yes yes yes -
Logo on brochure yes yes yes -
Logo on backdrop yes yes yes -
Logo on website yes yes yes yes
Promotion
Roll up poster 2 1 1 -
Advertisement on brochure One page One page One page Half page
Leaflet in bag yes yes yes -
Partnering
Prearranged meeting yes yes yes yes
Project follow up
Project information yes yes - -
SEBP2017 SEBP2017Sponsorship
A TAILORED PLATFORM FOR COLLABORATION
| Previous Chinese participants
| Previous European participants
SIMPLY MEET WITH THE BESTS
SINOPHARM • WISON • FOSUN PHARMA • KEHUA • BIOMABS • DIANDIAGNOSTICS • CP GUOJIAN • SUNDIA • UPPER BIOTECH • FRONTAGE •SHENZHEN TIME BOLE • HISUN PHARMA • HD BIOSCIENCES • SHANGHAIPHARMA • 3SBIO • WUXI APPTEC • SHANGPHARMA • MINDRAY • TIGERMED• NUOKANG BIOPHARM • T-MAB • FOUNTAINVEST PARTNERS • HUAMEDECINE • AB MART • ORBIMED • MEDICILON • WALVAX • MICROPOT •OMAHA CAPITAL • SHANGHAI BIOCHIP • BAYCITY CAPITAL • DAAN GENE •BSK VENTURES • ASCENTAGE PHARMA • WONDFO • HUA PHARMA • GENORBIOPHARMA • YANGTZE RIVER PHARMA • PIONEER PHARMA • LUYE PHARMA• KEYBAY • SIMCERE • HENGRUI MEDICINE • OSMUNDA • BEIXING CAPITAL •YUYUE • CHAI TAI TIANQING PHARMA • CROWNBIO • DT CAPITAL •EDDINGPARM • KINGMED DIAGNOSTICS • MORNINGSIDE • PHARMALEGACY• QIMING VENTURE • HENLIUS BIOTECH • ZERUN BIOTECH • CHINA GRAND •TASLY • WEGO • GREATER PACIFIC CAPITAL • FARMASINO • CHINA GRAND •FOSUN DIAGNOSITICS • JIUZHOU PHARM …
• Distributor• Pharma• Investor
• Medtech/IVD• CMO/CRO• Biotech
www.sebpchina.com
EUROPEAN AND US SME FOCUS
| Key topics:
|Showcase:
“Opportunities and Challenges of the future biomedical industry under the new medical policy in China”
LINK www.sebpchina.com
“I attended SEBP 2013 in Shanghai: I had a very positiveimpression. In my opinion, it is the right place to meet theChinese scientific community, to share opinions and businessopportunities, which must then be consolidated in severalseparate meetings. However, the proactive and informalatmosphere is very productive, and is a great facilitator forthe first contacts between different cultures and businessstyles. I consider the participation to SEBP a greatopportunity and the right investment for companies willingto explore potential partnerships into China.”
Dr. Domenico CriscuoloCEO Genovax (Italy)
“SEBP is a specialized partnering fair selecting specificspotlight topics of interest and which provides uniqueopportunity to share not only China market insights but alsoEuropean biotech and medical company’s development andcommercial focus. We did attend the conference severaltime, presenting our new products and technologies toChinese potential partners specially during the roadshow.These presentations were often followed by B2B discussionsand did initiate business opportunities. We do appreciatethe conference and wish great success in the followingyears.”
Dr. Thierry LeclipteuxCEO Coris BioConcept (Belgium)
“Cross border partnership and investment opportunities”
About twenty innovative companies from Europe, US and China will present their projects and business interests in drug development, biotech, IVD and medical devices sectors; Over 300 attendees from the industry and investment community will attend the conference
“The precision medicine impact to the global pharmaceutical industry development”
“How can innovation improve precision medicine?”
“Precision medicine practice in the cancer treatment”
SEBP2017REGISTRATION
[email protected] look forward to seeing you at SEBP2017!
Partners
Early Bird(before 15th April)
Regular(after 15th April)
On site(15th May)
Description
Conference pass
m Industry, Investor, Services 350 Euros * 400 Euros*
3500 RMB***
Conference pass gives access to keynote speeches, panel discussions, showcase and partnering sessions. The conference also provides simultaneous translation, buffet lunch & coffee break
m Academic, Individual, Organisation
300 Euros* 350 Euros*
Company presentation
q PresentationSubject to
application**Subject to
application**NA
Company will be given 10 minute slot to present its company(each slot is limited for one company)
* per person** per company (in addition to registration fee)*** Price per person, payable in RMB onlyTo enjoy the early bird rate, please register and arrange the payment before 16th of April.
Please register at: www.sebpchina.com
Ho
tel
http://RegalHotel.com
Room (RMB) Free
Deluxe Room 900 Breakfast and Internet
Premier Room 1100 Breakfast and Internet
Executive Room 1,600 Breakfast and Internet
Deluxe suite Room 3,200 Breakfast and Internet
The leading 5-star Regal International East Asia Hotel, is ideally located in the exclusive Hengshan Road. With cafés, bars, exquisite shops and beautifully arranged gardens scattered along the boulevard, this tree-lined promenade stretches to the two ends of famous commercial and leisure centers - Xu Jia Huiand Huai Hai Road. And the prestigious diplomatic district is within walking distance from Shanghai's best dining, shopping, night life and entertainment venues.
Our luxury Shanghai hotel comprises a total of 320 guest rooms. All our rooms are tastefully designed in a contemporary setting with hints of Oriental flair, offering guests tranquility and serenity in a relaxed environment.